Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05769634 · ClinicalTrials.gov registry record · NA
Electrophysiologic Studies of Cognition in Epilepsy Patients
A NA study of Drug Resistant Epilepsy, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05769634: Completed NA study of Drug Resistant Epilepsy, sponsored by Icahn School of Medicine at Mount Sinai.
NCT05769634 is a NA study of Drug Resistant Epilepsy that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 20 participants, below the 33-participant average among 6 other Drug Resistant Epilepsy trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05769634, a NA study of Drug Resistant Epilepsy, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Interoception, or sensation from inside the body, is involved in a variety of clinical symptoms, such as tics, compulsions and negative mood. This study uses invasive recordings of brain activity and brain stimulation to better understand basic neural mechanisms of interoception and related behaviors. Outcomes of this study provide critical tools for future investigation into clinical symptoms that emerge from abnormal interoception.
Primary Outcome
The heartbeat evoked potential is a brain electrophysiological signal time locked to the "rpeak" of the cardiac signal and thought to reflect interoceptive sensation of baroreceptor firing in the chest cavity. The population average magnitude of the change in HEP following the experimental manipulation (mean, standard deviation, 95% confidence interval) will be reported.
Conditions Studied
Interventions
- BEHAVIORAL Stereoelectroencephalography
Study Locations (1)
New York
- Mount Sinai West - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-08-10 |
| Est. Completion | 2024-05-28 |
| Phase | NA |
What the finished NCT05769634 record still lists
NCT05769634 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 33-participant average among 6 other Drug Resistant Epilepsy trials with a reported enrollment target (39% lower).
The record links to 1 condition, with Drug Resistant Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which Stereoelectroencephalography is the first listed.
NCT05769634 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05769634 about?
NCT05769634 is a clinical study titled "Electrophysiologic Studies of Cognition in Epilepsy Patients". Interoception, or sensation from inside the body, is involved in a variety of clinical symptoms, such as tics, compulsions and negative mood. This study uses invasive recordings of brain activity and brain stimulation to better understand basic neural mechanisms of interoception and related behavior...
What is the current status of trial NCT05769634?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2022-08-10. Estimated completion is 2024-05-28.
What conditions does trial NCT05769634 study?
This clinical trial studies the following conditions: Drug Resistant Epilepsy.
What interventions are being tested in trial NCT05769634?
The interventions under investigation include: Stereoelectroencephalography (BEHAVIORAL).
Who is sponsoring clinical trial NCT05769634?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05769634 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Drug Resistant Epilepsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Low Intensity Focused Ultrasound Epilepsy: A Pilot Trial
RECRUITING · NA
-
Infrared Photobiomodulation in Humans With Epilepsy
RECRUITING · NA
-
Goals for Epilepsy Clinic Visits Trial
RECRUITING · NA
-
Novel Helmet Design in Patients With Seizures
COMPLETED · NA
-
The Efficacy of a Subanesthetic Doses of IV Ketamine in the Treatment Drug Resistant Epilepsy
RECRUITING · Phase 2
-
A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI